Screener
Corcept Therapeutics CORT Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $111,039 | $120,495 |
| Short-term marketable securities | 197,158 | 251,657 |
| Trade receivables, net of allowances | 76,920 | 59,786 |
| Inventory | 13,185 | 12,868 |
| Prepaid expenses and other current assets | 41,374 | 40,658 |
| Total current assets | 439,676 | 485,464 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's short-term investments?
- Corcept Therapeutics (CORT) reported short-term investments of $197.16M in Q2 2026.
- How has Corcept Therapeutics's short-term investments changed year-over-year?
- Corcept Therapeutics's short-term investments decreased by 17.7% year-over-year, from $239.48M to $197.16M.
- What is the long-term trend for Corcept Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Corcept Therapeutics's short-term investments has grown at a -7.1% compound annual growth rate (CAGR), from $364.51M to $251.66M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Corcept Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude